GlobeStar Therapeutics Corporation
GSTC · OTC
9/30/2023 | 9/30/2022 | 9/30/2021 | 9/30/2020 | |
|---|---|---|---|---|
| Market Cap | $1 | $2 | $14 | $2 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $2 | $2 | $14 | $2 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | -100% | – |
| Gross Profit | $0 | $0 | -$0 | -$0 |
| % Margin | – | – | – | -48,837.7% |
| EBITDA | $0 | -$1 | -$9 | -$0 |
| % Margin | – | – | – | -392,207.8% |
| Net Income | -$2 | -$1 | -$10 | -$1 |
| % Margin | – | – | – | -703,896.1% |
| EPS Diluted | -0.002 | -0.002 | -0.02 | -0.002 |
| % Growth | 0% | 88.2% | -1,027.8% | – |
| Operating Cash Flow | -$0 | -$0 | -$1 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$1 | -$0 |